영아 백일해의 임상 양상

The Clinical Features of Pertussis in Infancy

  • 김순주 (가톨릭대학교 의과대학 소아과학교실) ;
  • 김상은 (가톨릭대학교 의과대학 소아과학교실) ;
  • 김종현 (가톨릭대학교 의과대학 소아과학교실) ;
  • 이정현 (가톨릭대학교 의과대학 소아과학교실) ;
  • 오진희 (가톨릭대학교 의과대학 소아과학교실) ;
  • 고대균 (가톨릭대학교 의과대학 소아과학교실) ;
  • 성화영 (질병관리본부 국립보건연구원 감염병센터 결핵호흡기세균과) ;
  • 유재연 (질병관리본부 국립보건연구원 감염병센터 결핵호흡기세균과)
  • Kim, Soon Ju (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kim, Sang-Eun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kim, Jong-Hyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jung-Hyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Oh, Jin Hee (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Koh, Dae Kyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Sung, Hwa Young (Division of Tuberculosis and Bacterial Respiratory Infections, Center for Infectious Diseases National Institute of Health, Korea Center for Disease Control and Prevention) ;
  • Yu, Jae-Yon (Division of Tuberculosis and Bacterial Respiratory Infections, Center for Infectious Diseases National Institute of Health, Korea Center for Disease Control and Prevention)
  • 투고 : 2009.10.06
  • 심사 : 2009.11.04
  • 발행 : 2009.12.25

초록

목 적: 과거에는 비교적 흔했던 백일해는 DTP백신의 사용 이후 경험하기 어려운 질환이 되었다. 이 같은 상황은 DTP백신의 높은 방어효과에 의한 것이기도 하지만 실제로는 알고 있는 것보다 많은 환자가 발생하고 있으나 확진을 위한 검사법이 용이하지 않아 생기는 현상일 수도 있다. 따라서 본 연구에서는 발작적 기침을 주증상으로 입원한 영아들에게 백일해에 대한 검사를 적극적으로 수행하여 백일해로 진단되는 비율을 얻음과 동시에, 백일해로 확진된 환자들과 비백일해 대조군의 임상양상을 비교함으로써 본 질환에 대한 보다 높은 관심을 이끌고자 하였다. 방 법: 2006년 6월부터 11월까지 가톨릭대학교 성빈센트병원 소아청소년과에 입원한 생후 15-90일의 영아 중 1주일 이상 기침이 지속되고, 발작적 기침이나 흡기 시 '흡' 소리, 기침 후 구토가 있었던 환자 27명의 비인두 가검물로 백일해에 대한 PCR 및 배양검사를 시행하였다. 백일해에 대한 PCR 양성이나 배양검사에서 균이 자란 경우를 백일해 환자군, PCR음성이면서 배양검사에서 균이 자라지 않은 경우를 비백일해 대조군으로 정의하고 두 군간의 임상양상을 비교하였다. 결 과 : 연구 대상 27명의 입원시 진단명은 세기관지염 20명, 기관지 폐렴 1명, 백일해양 증후군 6명이었다. 백일해로 확진된 5명 중 1명(20%)만이 입원 시의 진단명이 백일해양 증후군이었다. 백일해 환자군과 비백일해 대조군의 임상양상을 비교한 결과 환자군에서 의미 있게 높은 빈도를 보였던것은 무발열(P =0.043), 발작적 기침(P =0.040), 청색증(P =0.001), DTaP백신 미접종(P =0.003), 정상 청진소견(P =0.028), 가슴 X-선 사진의 정상소견(P =0.027), 절대 림프구수(P =0.039), 낮은 CRP 수치(P =0.046)이었으며, 총 기침기간은 백일해 환자군에서 비백일해 대조군에 비해 길었다 (27.2${\pm}$10.6 vs. 12.6${\pm}$5.6일, P =0.039). 결 론: 백일해로 확진된 영아의 일부만이 입원 시의 진단명이 백일해양 증후군이었다. 따라서 전형적인 백일해 증상이 있는 경우는 물론, 열이 없이 1주일 이상 발작적 기침이 지속되거나 청색증이 동반되는 DTaP 백신 접종력이 없는 영아들에서는 백일해의 가능성을 반드시 염두에 두어 이에 대한 적극적인 검사를 고려해야 하겠다.

Purpose : Pertussis was very common in the past, but reported cases have dramatically decreased. The improvement of vaccination programs and unreadiness of laboratory confirmation seems to have developed this situation. This study investigated the frequency of pertussis among infants with a paroxysmal cough and compared the clinical characteristics between infants with and without pertussis. Methods : Between June and November 2006, 27 infants admitted to the hospital that were 15-90 days old with a history of a cough for more than seven days were enrolled. The cough was described as: paroxysmal, whooping, and post-tussive vomiting. PCR and cultures for Bordetella pertussis with nasopharyngeal aspirates were obtained. The patients were divided into two groups: (1) the pertussis group that had positive results by PCR or culture; (2) the control group that had negative results by PCR and culture. Clinical and laboratory characteristics were compared between the two groups. Results : Among the 27 cases, five (18.5%) were finally diagnosed with pertussis. Only one out of the five pertussis cases was initially diagnosed with a pertussis-like syndrome on admission. Compared to the group without pertussis, the pertussis group had a significantly higher frequency of: no fever (P =0.043), a paroxysmal cough (P =0.040), cyanosis (P =0.001), non-immunized status for DTaP (P =0.047), normal auscultation (P =0.028), normal chest X-ray findings (P =0.027), high absolute lymphocyte count (P =0.039), and low CRP (P =0.046). The patients with the diagnosis of pertussis had a significantly longer duration of coughing (27.2${\pm}$10.6 vs. 12.6${\pm}$5.6 days, P =0.039). Conclusion : Pertussis should be suspected in any infant with typical symptoms of pertussis in addition to: a persistent cough without fever, accompanied by paroxysms or cyanosis prior to the age of DTaP immunization. Active laboratory confirmation should be carried out to confirm more cases with pertussis.

키워드

참고문헌

  1. Cherry JD, Heininger U. Pertussis and other Bordetella infections. In : Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Feigin and Cherry's textbook of pediatric infectious diseases. 6th ed. Philadelphia : Saunders Co, 2009:1683-706.
  2. Department of Vaccines and Biologicals, World Health Organization. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva : WHO, 2003:28-30.
  3. Division of Tuberculosis and Bacterial Respiratory Infections, Korea National Health Institute. The report of a survey for pertussis infection status in Korea. Seoul : Korea National Health Institute, 2007:95-110.
  4. Miller E. Overview of recent clinical trials of acellular pertussis vaccine. Biologicals 1999;27:79-86. https://doi.org/10.1006/biol.1999.0184
  5. Liese JG, Meschievitz CK, Harzer E, Froeschle J, Hosbach P, Hoppe JE, et al. Efficacy of two-component acellular pertussis vaccine in infants. Pediatr infect Dis J 1997; 16:1038-44. https://doi.org/10.1097/00006454-199711000-00007
  6. de Carvalho AP, Pereira EM. Acellular pertussis vaccine for adolescents. J Pediatr (Rio J) 2006;82 Suppl 3:S15- 24. https://doi.org/10.1590/S0021-75572006000400003
  7. Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997;350:1569-77. https://doi.org/10.1016/S0140-6736(97)06508-2
  8. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005;24 Suppl 5:S10-8. https://doi.org/10.1097/01.inf.0000160708.43944.99
  9. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J 2006;25:361-2. https://doi.org/10.1097/01.inf.0000210478.60841.69
  10. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001;32:1691-7. https://doi.org/10.1086/320754
  11. Hoppe JE. Bordetella. In : Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington, D.C. : American Society for Microbiology, 1999:614-24.
  12. Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977;6:303-9.
  13. Nelson S, Matlow A, McDowell C, Roscoe M, Karmali M, Penn L, et al. Detection of Bordetella pertussis in clinical specimens by PCR and a microtiter plate-based DNA hybridization assay. J Clin Microbiol 1997;35: 117-20.
  14. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18:326-82. https://doi.org/10.1128/CMR.18.2.326-382.2005
  15. Centers for Disease Control and Prevention. Pertussis outbreak-Vermont, 1996. MMWR Morb Mortal Wkly Rep 1997;46:822-6.
  16. Department of Vaccine and Biologicals, World Health Organization. Pertussis surveillance: a global meeting Geneva, 16-18 October 2000. Geneva : WHO, 2001: 28-30.
  17. Guinto-Ocampo H, Bennett JE, Attia MW. Predicting pertussis in infants. Pediatr Emerg Care 2008;24:16-20.
  18. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003;290:2968- 75. https://doi.org/10.1001/jama.290.22.2968
  19. Brooksaler F, Nelson JD. Pertussis: a reappraisal and report of 190 confirmed cases. Am J Dis Child 1967; 114:389-96. https://doi.org/10.1001/archpedi.1967.02090250087005
  20. Yoo S, Ahn KO, Park EH, Cho HS, Park CY, Lee HR. Epidemiologic and clinical features of pertussis in children. J Korean Pediatr Soc 2002;45:603-8.
  21. Munoz FM. Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention. Semin Pediatr Infect Dis 2006;17:14-9. https://doi.org/10.1053/j.spid.2005.11.005
  22. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005;24 Suppl 5:S25-34. https://doi.org/10.1097/01.inf.0000160926.89577.3b
  23. Riffelmann M, Wirsing von König CH, Caro V, Guiso N. Pertussis PCR Consesus Group. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005;43:4925-9. https://doi.org/10.1128/JCM.43.10.4925-4929.2005
  24. Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. Comparison of PCR, culture, and direct fluorescentantibody testing for detection of Bordetella pertussis. J Clin Microbiol 1999;37:2872-6.
  25. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 1995;171: 1650-2. https://doi.org/10.1093/infdis/171.6.1650
  26. De Serres G, Shadmani R, Duval B, Boulianne N, Déry P, Douville Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000;182:174-9. https://doi.org/10.1086/315648